Multifocal atherosclerosis: epidemiology and treatment adherence

Gaygiev T.I.; Borovikova O.A.; Nikolaev N.A.

doi:https://doi.org/10.17116/profmed202427081107

Close metadata

Recommended articles:

Independent adverse outcomes predictors in patients with stable coronary heart disease after scheduled percutaneous coronary interventions. Russian Journal of Preventive Medicine. 2024;(11):94-101

Improving an automatic stress test analysis protocol as a problem solution for sympatho-dependent arrhythmias identification. Russian Journal of Preventive Medicine. 2024;(11):115-121

Reclassification of ischemic heart disease epidemiological criteria. Russian Journal of Preventive Medicine. 2024;(12):61-68

Effectiveness of the second stage program of medical rehabilitation of patients with ischemic heart disease. Russian Journal of Preventive Medicine. 2024;(12):75-80

Incidence of diseases of the circulatory system in the working-age population of the Ural Federal District in 2012—2022. Russian Journal of Preventive Medicine. 2025;(1):24-29

Cost-effectiveness of using rubidium-82 chloride perfusion PET for planning myocardial revascularization procedures. Pirogov Russian Journal of Surgery. 2024;(12-2):58-65

Moderate ischemic mitral insufficiency with severe left ventricular dysfunction: surgical treatment depending on predictors of adverse long-term outcomes. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(6):651-659

Radionuclide methods in analysis of myocardial perfusion and metabolic activity. Regenerative Biotechnologies, Preventive, Digital and Predictive Medicine. 2024;(4):12-19

Endovascular correction of lesions of coronary arteries and coronary artery bypass grafts in patients with coronary artery disease with recurrent ischemia after surgical myocardial revascularization. Russian Cardiology Bulletin. 2024;(4):34-40

Refralon for drug-induced cardioversion of atrial fibrillation in patients with coronary artery disease. Russian Cardiology Bulletin. 2024;(4-2):188-196

Abstract:

Cardiovascular diseases are the leading cause of morbidity and mortality all over the world. Multifocal atherosclerosis refers to an atherosclerotic lesion of two or more vascular beds. This concept was introduced into medical practice due to the systemic character of atherosclerosis in such patients prone to disease progression and worsening prognosis. This paper analyses the original studies on the topic. The revealed high incidence of multifocal atherosclerosis determines the medical and social significance of this problem. Low adherence of patients with multifocal atherosclerosis to treatment significantly neutralizes the effect of ongoing preventive and therapeutic measures.

Keywords:

multifocal atherosclerosis

peripheral artery disease

coronary heart disease

treatment adherence

Authors:

Gaygiev T.I.

Clinical Medical and Sanitary Unit No. 9

ORCID: 0000-0002-1409-7531

Borovikova O.A.

Clinical Medical and Sanitary Unit No. 9

ORCID: 0000-0003-2720-0953

Nikolaev N.A.

Omsk State Medical University

ORCID: 0000-0002-3758-4930

Received:

26.02.2024

Accepted:

01.04.2024

Close metadata

References:

10 vedushhix prichin smerti v mire. Accessed February 20, 2024. (In Russ.). https://www.who.int/ru/news-room/fact-sheets/detail/the-top-10-causes-of-death
Zdravookhranenie v Rossii. 2023. Stat. sb. Rosstat. M. 2023;179. Accessed February 20, 2024. (In Russ.). https://rosstat.gov.ru/storage/mediabank/Zdravoohran-2023.pdf
Luca AC, David SG, David AG, et al. Atherosclerosis from Newborn to Adult-Epidemiology, Pathological Aspects, and Risk Factors. Life (Basel). 2023;13(10):2056. https://doi.org/10.3390/life13102056
2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the european society for vascular surgery (ESVS). Rossijskij kardiologicheskij zhurnal. 2018;(8):164-221. (In Russ.). https://doi.org/10.15829/1560-4071-2018-8-164-221
Klinicheskaya kardiologiya: diagnostika i lechenie. V 3 t. Pod red. Bokeriya L.A., Goluxovoy E.Z. M.: Izd-vo NCzSSX im. A.N. Bakuleva; 2011. (In Russ.).
Meizels A, Zeitoun DM, Bataille V, et al.; ALLIANCE investigators on behalf of the working group on Epidemiology of the French Society of Cardiology. Impact of polyvascular disease on baseline characteristics, management and mortality in acute myocardial infarction. The Alliance project. Archives of Cardiovascular Diseases. 2010;103(4):207-214. https://doi.org/10.1016/j.acvd.2010.02.002
Stojanović SD, Fiedler J, Bauersachs J, et al. Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis. European Heart Journal. 2020;41(31):2983-2996. https://doi.org/10.1093/eurheartj/ehz919
Krempf M, Parhofer KG, Steg PG, et al.; Reach Registry Investigators. Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry). The American Journal of Cardiology. 2010;105(5):667-671.
Bhatt DL, Peterson ED, Harrington RA, et al.; CRUSADE Investigators. Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes. European Heart Journal. 2009;30(10):1195-1202. https://doi.org/10.1093/eurheartj/ehp099
Fowkes FG, Low LP, Tuta S, et al.; AGATHA Investigators. Ankle-brachial index and extent of atherothrombosis in 8891 patients with or at risk of vascular disease: results of the international AGATHA study. European Heart Journal. 2006;27(15):1861-1867. https://doi.org/10.1093/eurheartj/ehl114
Sumin AN, Korok EV, Gaĭfulin RA, et al. Gender-specific features of the prevalence and clinical manifestations of multifocal atherosclerosis. Klinicheskaia meditsina. 2014;92(1):34-40. (In Russ.).
Sumin AN, Gaĭfulin RA, Bezdenezhnykh AV, et al. Prevalence of multifocal atherosclerosis in different age group. Kardiologiia. 2012;52(6):28-34. (In Russ.).
Barbarash OL, Zykov MV, Kashtalap VV, Barbarash LS. Prevalence and clinical significance of multifocal atherosclerosis in patients with ischemic heart disease. Kardiologiia. 2011;51(8):66-71. (In Russ.).
Prudnikov AR, Shchupakova AN. Multifocal atherosclerosis is one of the main risk factors accelerating the development of acute cardiovascular events. Meditsinskii akademicheskii zhurnal. 2018;18(2):29-42. (In Russ.). https://doi.org/10.17816/MAJ18229-42
Barbarash LS, Sumin AN, Bezdenezhnykh AV, et al. Prevalence of polyvascular disease in patients with ischemic heart disease. Kompleksnye problemy serdechno-sosudistyh zabolevanij. 2013;(3):4-11. (In Russ.).
Krivosheeva EN, Komarov AL, Galyautdinov DM, et al. Long-term outcomes of coronary bypass surgery in patients with widespread atherosclerotic lesions of the coronary and peripheral vascular basins (according to the registry of long-term antithrombotic therapy REGATA). Aterotromboz. 2021; 11(2):30-43. (In Russ.).
Sumin AN, Moskin MG, Bezdenezhnyh AV, et al. Effect of polyvascular disease on quality of life of coronary artery disease patients. Kompleksnye problemy serdechno-sosudistyh zabolevanij. 2014;(1):36-41. (In Russ.).
Bhalke JB, Hiremath S, Makhale CN. A cross-sectional study on coronary artery disease diagnosis in patients with peripheral artery disease. Journal of Interventional Medicine. 2022;5(4):184-189. https://doi.org/10.1016/j.jimed.2022.09.005
Alekyan BG, Pokrovsky AV, Karapetyan NG, Revishvili ASh. A multidisciplinary approach in determining of prevalence of coronary artery disease and treatment strategies in patients with pathology of the aorta and peripheral arteries. Rossijskij kardiologicheskij zhurnal. 2019;(8):8-16. (In Russ.). https://doi.org/10.15829/1560-4071-2019-8-8-16
Gallino A, Aboyans V, Diehm C, et al; European Society of Cardiology Working Group on Peripheral Circulation. Non-coronary atherosclerosis. European Heart Journal. 2014;35(17):1112-1119. https://doi.org/10.1093/eurheartj/ehu071
Cho I, Chang HJ, Sung JM, et al; CONFIRM Investigators. Coronary computed tomographic angiography and risk of all-cause mortality and nonfatal myocardial infarction in subjects without chest pain syndrome from the CONFIRM Registry (coronary CT angiography evaluation for clinical outcomes: an international multicenter registry). Circulation. 2012;126(3):304-313. https://doi.org/10.1161/.111.081380
Bhatt DL, Peterson ED, Harrington RA, et al; CRUSADE Investigators. Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes. European Heart Journal. 2009;30(10):1195-1202. https://doi.org/10.1093/eurheartj/ehp099
Dudanov IP, Belinskaya VG, Vasilchenko NO, et al. Experience in providing care to patients with symptomatic carotid artery stenosis in the acute period of ischemic stroke. Vestnik novykh meditsinskikh tekhnologii. 2011; XVIII(4):206-209. (In Russ.).
Aboyans V, Lacroix P, Guilloux J, et al. A predictive model for screening cerebrovascular disease in patient undergoing coronary artery bypass grafting. Interactive Cardiovascular and Thoracic Surgery. 2005;4:90-95. https://doi.org/10.1510/icvts.2004.092262
Drohomirecka A, Koltowski L, Kwinecki P, et al. Risk factors for carotid artery disease in patients scheduled for coronary artery bypass grafting. Kardiologia polska. 2010;68(7):789-794.
Avilova MV, Kosmacheva ED. Multifocal atherosclerosis: the problem of combined damage to the coronary and brachiocephalic basins. Kreativnaya kardiologiya. 2013;(1):5-13. (In Russ.).
Razzouk L, Rockman CB, Patel MR, et al. Coexistence of vascular disease in different arterial beds: Peripheral artery disease and carotid artery stenosis — data from Life Line Screening. Atherosclerosis. 2015;241(2):687-691. https://doi.org/10.1016/j.atherosclerosis.2015.06.029
Ahmed B, Al-Khaffaf H. Prevalence of significant asymptomatic carotid artery disease in patients with peripheral vascular disease: a meta-analysis. European Journal of Vascular and Endovascular Surgery. 2009;37(3):262-271. https://doi.org/10.1016/j.ejvs.2008.10.017
Chaudri NA. Adherence to Long-term Therapies Evidence for Action. Annals of Saudi Medicine. 2004;24(3):221-222. https://doi.org/10.5144/0256-4947.2004.221
Sedykh DYu, Petrov GP, Kashtalap VV. Differences in adherence behaviour patterns in patients with primary and recurrent myocardial infarction. Kompleksnye problemy serdechno-sosudistyh zabolevanij. 2018;7(4):15-25. (In Russ.). https://doi.org/10.17802/2306-1278-2018-7-4-15-25
Sedykh DYu, Kashtalap VV, Gorbunova EV. Impact of secondary prevention educational program on anxiety, quality of life, and compliance in patients with myocardial infarction. Fundamental’naja i klinicheskaja medicina. 2019;4(1):40-46. (In Russ.).
Sedykh DYu. Adherence to treatment in patients with myocardial infarction in combination with cerebral atherosclerosis. Kompleksnye problemy serdechno-sosudistykh zabolevanii. 2017;(S4):38. (In Russ.).
Khunti K, Danese MD, Kutikova L, et al. Association of a Combined Measure of Adherence and Treatment Intensity With Cardiovascular Outcomes in Patients with Atherosclerosis or other Cardiovascular Risk Factors Treated with Statins and/or Ezetimibe. JAMA Network Open. 2018;1(8):e185554. https://doi.org/10.1001/jamanetworkopen.2018.5554
Desai NR, Farbaniec M, Karalis DG. Nonadherence to lipid-lowering therapy and strategies to improve adherence in patients with atherosclerotic cardiovascular disease. Clinical Cardiology. 2023;46(1):13-21. https://doi.org/10.1002/clc.23935
Chen DC, Armstrong EJ, Singh GD, et al. Adherence to guideline-recommended therapies among patients with diverse manifestations of vascular disease. Vascular Health and Risk Management. 2015;11:185-192. https://doi.org/10.2147/VHRM.S76651
Striberger R, Zarrouk M, Kumlien C, et al. Illness perception, health literacy, self-efficacy, adherence and quality of life in patients with intermittent claudication — a longitudinal cohort study. BMC Nursing. 2023;(22):167. https://doi.org/10.1186/s12912-023-01329-2
Eisenberger U, Wüthrich RP, Bock A, et al. Medication adherence assessment: high accuracy of the new Ingestible Sensor System in kidney transplants. Transplantation. 2013;96(3):245-250.
Nikolaev NA, Martynov AI, Skirdenko YuP, et al. Priverzhennost lecheniyu. Rossiiskoe natsionalnoe rukovodstvo. M.: Izdatelskii dom Akademii estestvoznaniya; 2022. (In Russ.).
Lukina YuV, Kutishenko NP, Martsevich SYu, Drapkina OM. Questionnaires and scores for assessing medication adherence — advantages and disadvantages of the diagnostic method in research and actual clinical practice. Kardiovaskulyarnaya terapiya i profilaktika. 2020;19(3):2562. (In Russ.). https://doi.org/10.15829/1728-8800-2020-2562
Osterberg L, Blaschke T. Adherence to medication. The New England journal of medicine. 2005;(353):487-497. https://doi.org/10.1056/NEJMra050100
Kenefick H, Lee J, Fleishman V. Improving Physician Adherence to Clinical Practice Guidelines. Barriers and Strategies for Change. London, UK: New England Healthcare Institute; 2008.
Nikolaev NA, Martynov AI, Skirdenko YuP, et al. Priverzhennost v klinicheskoi praktike: Mezhdunarodnoe metodicheskoe rukovodstvo. M.: Izdatelskii dom Akademii Estestvoznaniya. 2023. (In Russ.).